CompanyGraph
Shanghai Kindly Enterprise Development Group Co., Ltd.
603987 · SSE · China
kdlchina.cnFinancials as of FY2025
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleLevered free cash flow is $24.02M, above the global median of $16.24M
- FinancialsAltman Z-Score 3.35: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.27%
Annual Rate
CNY 0.17Paid annual
Payout Ratio
28.3%Sustainable
Payback Period
44.0 yr
Last Ex-Dividend
Jun 3, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.36BCNY500.15M · vs all stocks (USD)
Trailing P/E
14.53xvs Medical Instruments & Supplies peers
Revenue (TTM)
2.29BCNY340.10M · vs all stocks (USD)
Profit Margin
10.22%vs Medical Instruments & Supplies peers
Beta
0.3120xvs all stocks
52-Week Change
-14.89%vs all stocks
Market Capitalization
3.36BCNY500.15M · vs all stocks (USD)
Enterprise Value
3.75BCNY557.90M · vs all stocks (USD)
Trailing P/E
14.53xvs Medical Instruments & Supplies peers
Forward P/E
7.62xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
1.47xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.18xvs Medical Instruments & Supplies peers
Enterprise to Revenue
1.64xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
9.15xvs Medical Instruments & Supplies peers
Gross Margin
31.50%vs Medical Instruments & Supplies peers
Profit Margin
10.22%vs Medical Instruments & Supplies peers
Operating Margin
12.40%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
3.97%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
8.30%vs Medical Instruments & Supplies peers
Revenue (TTM)
2.29BCNY340.10M · vs all stocks (USD)
Revenue per Share (TTM)
5.18CNYUpdated Aug 21, 2026Quarterly Revenue Growth
-2.10%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
749.58MCNY111.47M · vs all stocks (USD)
EBITDA (TTM)
309.28MCNY45.99M · vs all stocks (USD)
Net Income (TTM)
233.71MCNY34.76M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-10.90%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
397.87MCNY59.17M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
161.51MCNY24.02M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1700CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
2.27%vs all stocks
Payout Ratio
28.30%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
341.04MCNYFY2025 · Dec 31, 2025Revenue
2.30BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.54BCNYFY2025 · Dec 31, 2025Gross Profit
759.93MCNYFY2025 · Dec 31, 2025Operating Income
291.02MCNY43.28M · vs all stocks (USD)
Pre-tax Income
307.63MCNYFY2025 · Dec 31, 2025Income Tax Expense
46.55MCNYFY2025 · Dec 31, 2025Net Income
261.08MCNYFY2025 · Dec 31, 2025EBIT
324.65MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
498.05MCNYFY2025 · Dec 31, 2025Research & Development
90.48MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
122.09MCNYFY2025 · Dec 31, 2025Other Operating Expenses
25.91MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
2.32MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
17.02MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.5500CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.5500CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
437.00MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
437.00MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
261.08MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-20.73MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
232.16MCNYFY2025 · Dec 31, 2025Free Cash Flow
86.09MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
472.10MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
261.08MCNYFY2025 · Dec 31, 2025Other Non-cash Items
19.46MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-93.64MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
45.26MCNYFY2025 · Dec 31, 2025Capital Expenditures
-146.07MCNYFY2025 · Dec 31, 2025Net Acquisitions
18.73MCNYFY2025 · Dec 31, 2025Purchase of Investments
-3.00MCNYFY2025 · Dec 31, 2025Sale of Investments
1.98MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-128.35MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
656.90MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-712.45MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-83.11MCNYFY2025 · Dec 31, 2025Other Financing Charges
-6.28MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-144.94MCNYFY2025 · Dec 31, 2025Shares Outstanding
436.79MSharesUpdated Aug 21, 2026Float Shares
249.29MSharesUpdated Aug 21, 2026% Held by Insiders
43.75%vs all stocks
% Held by Institutions
3.06%vs all stocks
Total Cash (MRQ)
425.11MCNY63.22M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.9730CNYUpdated Aug 21, 2026Total Debt (MRQ)
571.94MCNY85.05M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1791xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.88xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
6.52CNYUpdated Aug 21, 2026Total Assets
4.19BCNY623.48M · vs all stocks (USD)
Total Current Assets
1.92BCNYFY2025 · Dec 31, 2025Total Liabilities
1.14BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.27BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
49.57MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.09BCNYFY2025 · Dec 31, 2025Cash
472.10MCNYFY2025 · Dec 31, 2025Cash Equivalents
19.85MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
491.95MCNYFY2025 · Dec 31, 2025Accounts Receivable
961.50MCNYFY2025 · Dec 31, 2025Inventory
383.03MCNYFY2025 · Dec 31, 2025Accounts Payable
300.99MCNYFY2025 · Dec 31, 2025Short-term Debt
553.19MCNYFY2025 · Dec 31, 2025Other Current Liabilities
7.15MCNYFY2025 · Dec 31, 2025Long-term Debt
3.71MCNYFY2025 · Dec 31, 2025Common Stock (Book)
436.79MCNYFY2025 · Dec 31, 2025Retained Earnings
1.59BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.06BCNY454.51M · vs all stocks (USD)
52-Week Low
6.72CNYUpdated Aug 21, 202652-Week High
10.23CNYUpdated Aug 21, 202652-Week Change
-14.89%vs all stocks
Beta
0.3120xvs all stocks
50-Day MA
7.29CNYUpdated Aug 21, 2026200-Day MA
8.37CNYUpdated Aug 21, 2026Avg 10-Day Volume
4.99MSharesUpdated Aug 21, 2026Avg 30-Day Volume
4.56MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.5300CNYUpdated Aug 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.35: safe zoneNotable
Altman Z-Score: 3.35
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Levered free cash flow is $24.02M, above the global median of $16.24MNotable
Levered free cash flow (USD): 24,018,547.074Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Shanghai Huide Science & Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Hektaş Ticaret T.A.Ş.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Surya Roshni Ltd.
Tier 1ProductionThroughput-Bound ConversionFlow
Shandong Chiway Industry Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hefei Conver Holding Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
D&O Home Collection Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowAttention
Jilin Joinature Polymer Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Natural Gas Services Group, Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Zhongjin Irradiation Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Shandong Shuangyi Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Zhejiang Sunoren Solar Technology Co., Ltd.
1 interpretationPrice Below Mean With Profitability And Book Value
Yangzhou Jinquan Tourism Co., Ltd.
1 interpretationPrice Below Mean With Profitability And Book Value
AB Dynamics plc
1 interpretationPrice Below Mean With Profitability And Book Value